Osteoporosis
📧 Sign up to get email alerts when something new happens for Osteoporosis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2026-03-31Clinical Trial Update: Five-Year CT Follow-Up of Vertebral Fracture Risk Using Opportunistic Osteoporosis Screening
Five-year CT follow-up study evaluating vertebral fracture risk and the utility of opportunistic osteoporosis screening.
-
EMA approval · 2026-03-31EMA Authorised: Zoledronic acid Mylan (zoledronic acid) — Mylan Pharmaceuticals Limited
The European Medicines Agency authorised Zoledronic acid Mylan (zoledronic acid) for bone/fracture indications. The product is manufactured …
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Deep Learning for Musculoskeletal Complications in Breast Cancer
A clinical trial employing deep learning to study musculoskeletal complications following breast cancer surgery, currently in recruitment.
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Osteoporosis After Stroke
The clinical trial investigating osteoporosis after stroke has completed. The update notes the status but does not provide trial results in …
-
CLINICAL_TRIALS research · 2026-03-25Clinical Trial Update: Metabolic Profiling of Hematopoietic Stem Cells in Clonal Hematopoiesis (CHIP)
This clinical trial update indicates a study on metabolic profiling of hematopoietic stem cells in clonal hematopoiesis of indeterminate pot…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Autophagy and Pathological Aging [NA]
A completed clinical trial (NCT03175874) on autophagy and pathological aging conducted at Centre Hospitalier Universitaire de Nice investiga…
-
EMA approval · 2026-03-23EMA Authorised: Sondelbay (teriparatide) — Accord Healthcare S.L.U.
EMA authorised Sondelbay (teriparatide) by Accord Healthcare S.L.U. for osteoporosis, marking EU marketing authorisation. Decision date: 23/…
-
EMA approval · 2026-03-20EMA Authorised: Evfraxy (denosumab) — Biosimilar Collaborations Ireland Limited
EMA authorised Evfraxy (denosumab) as a biosimilar; it is approved for bone resorption disorders including osteoporosis and postmenopausal o…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: Effect of Biofeedback Activation on Balance in Osteoporotic Elderly [NA]
A clinical trial is evaluating the effect of biofeedback activation on balance in elderly individuals with osteoporosis and is currently rec…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Biobank for Inflammatory Chronic Diseases and Osteoporosis
The Biobank for Inflammatory Chronic Diseases and Osteoporosis study is currently recruiting and will collect samples from patients with inf…
-
CLINICAL_TRIALS research · 2026-03-19Clinical Trial Update: Evaluation of Musculoskeletal Aging and Related Disorders Via Advanced Clinical Imaging
A clinical trial sponsored by Peking University People's Hospital is evaluating musculoskeletal aging and related disorders using advanced c…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Synbiotic to Attenuate Resorption of the Skeleton [NA]
A clinical trial is recruiting to evaluate a synbiotic intended to attenuate resorption of bone in osteoporosis, with inflammation and aging…
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Patient Education in Osteoporosis (RCT-PATOS) [NA]
A clinical trial update describing the RCT-PATOS study on patient education for osteoporosis; the study is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-11Clinical Trial Update: Evaluation of Dora Care for Supporting Fracture Liaison Services (FLS) [NA]
Clinical trial evaluating Dora Care to support fracture liaison services for osteoporosis risk assessment and bone health management; the st…
-
CLINICAL_TRIALS trial_result · 2026-03-10Clinical Trial Update: Resveratrol for the Prevention of Bone Loss in Postmenopausal Women [NA]
A completed clinical trial evaluating resveratrol for prevention of bone loss in postmenopausal women with low bone mass.
-
CLINICAL_TRIALS research · 2026-03-09Clinical Trial Update: Romosozumab Effects on Bone Density, Muscle Mass, and Spine Surgery Outcomes [Phase 2]
Phase 2 clinical trial evaluating romosozumab effects on bone density, muscle mass, and spine surgery outcomes in osteoporosis, with status …
-
CLINICAL_TRIALS other · 2026-03-06Clinical Trial Update: Low Frequency Ultrasound for Osteoarthritis Healing and Rehabilitation [NA]
Clinical trial NCT06562374 sponsored by The University of Texas Medical Branch evaluating low-frequency ultrasound for osteoarthritis of the…
-
EMA approval · 2026-03-04EMA Authorised: Kefdensis (denosumab) — Stada Arzneimittel AG
The European Medicines Agency authorised Kefdensis, a denosumab medicine by STADA Arzneimittel AG, for osteoporosis indications including po…
-
FDA approval · 2026-03-04FDA Approved: CALCITONIN SALMON — Original Application (Zydus Pharmaceuticals USA Inc.)
FDA approves Zydus Pharmaceuticals USA Inc.'s Original Application for Calcitonin Salmon, a generic version of the established drug. This ap…
-
CLINICAL_TRIALS research · 2026-03-04Clinical Trial Update: Bone Loss Prevention With Zoledronic Acid or Denosumab in Critically Ill Adults [Phase 2]
This ClinicalTrials.gov update reports a Phase 2 study evaluating zoledronic acid or denosumab to prevent bone loss in critically ill adults…
-
CLINICAL_TRIALS research · 2026-03-03Clinical Trial Update: Comparison of Bone Microarchitecture Analysed by HRpQCT and pQCT in Pathologies With Bone Loss and/or Muscle Loss [NA]
This trial update describes a study comparing bone microarchitecture analyses by HR-pQCT and pQCT in conditions involving bone and/or muscle…
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: AI-Generated Audiovisual Education and Osteoporosis Knowledge [NA]
This completed clinical trial evaluated the impact of AI-generated audiovisual education on osteoporosis knowledge.
-
CLINICAL_TRIALS research · 2026-02-27Clinical Trial Update: The Investigation of the Effectiveness of Virtual Reality Applications in Postmenopausal Osteoporosis Patients [NA]
This clinical trial update describes an ongoing study evaluating the effectiveness of virtual reality applications in postmenopausal osteopo…
-
EMA approval · 2026-02-26EMA Authorised: Conexxence (denosumab) — Fresenius Kabi Deutschland GmbH
EMA authorised Conexxence, a denosumab product from Fresenius Kabi Deutschland GmbH, for osteoporosis including postmenopausal osteoporosis.…
-
CLINICAL_TRIALS research · 2026-02-25Clinical Trial Update: The Osteoporotic Fracture Classification-based Scoring System for Treatment Decision in Thoracolumbar Osteoporotic Fractures
A clinical trial update indicating that recruitment is ongoing for a scoring system based on Osteoporotic Fracture Classification to guide t…